Arkolith/Insider Trading/NASD/Form 4

Greenfield Andrew J

VP, CHIEF COMMERCIAL OFFICERABIOMED INC (NASD) · full profile →Form 4 · filed Dec 27, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
1 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2022Disposed to issuer(D)23K—$00

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 22, 2022Disposed to issuer(D)3K——0
Dec 22, 2022Grant(A)27K——27K
Dec 22, 2022Disposed to issuer(D)27K——0
Dec 22, 2022Disposed to issuer(D)5K——0
Dec 22, 2022Disposed to issuer(D)4K——0
Dec 22, 2022Disposed to issuer(D)7K——0
Dec 22, 2022Disposed to issuer(D)5K——0
Dec 22, 2022Disposed to issuer(D)7K——0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-22-013015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML